Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | KCNA5 | P22460 | 3/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28598390 | 0.87 | ESR1 (0.50) | ALDH1A1 | |
| SCHEMBL3930254 | 0.83 | MEN1 (0.40) | TSHRALDH1A1KCNA5SRC | |
| SCHEMBL1053425 | 0.79 | KCNA5 (0.47) | KCNN4ALDH1A1KCNA5CYP2D6MAPK1 | |
| SCHEMBL1053427 | 0.79 | KCNA5 (0.47) | KCNN4ALDH1A1KCNA5CYP2D6MAPK1 | |
| SCHEMBL17931025 | 0.78 | TSHR (0.39) | TSHRKCNN4DPP4F2ALDH1A1 | |
| SCHEMBL9209099 | 0.76 | KIF11 (0.40) | TSHRALDH1A1CYP2D6 | |
| SCHEMBL6741619 | 0.76 | TAAR1 (0.41) | KCNN4DPP4F2ALDH1A1TAAR1 | |
| Ethane SCHEMBL29156734 | 0.75 | CYP2D6 (0.46) | KCNN4ALDH1A1KCNA5CYP2D6MAPK1 | |
| SCHEMBL9319014 | 0.74 | KCNN4 (0.48) | TSHRKCNN4DPP4F2ALDH1A1 | |
| SCHEMBL8662376 | 0.74 | TSHR (0.36) | TSHRKCNN4DPP4F2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1074 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4602086-A1 | PHOTOCURABLE COMPOSITIONS FOR THREE-DIMENSIONAL INVESTMENT PATTERN CASTING AND USE THEREOF | Henkel AG & Co. KGaA (DE) | 2025-08-20 | — | — | EP | claimed |
| EP-4602083-A1 | PHOTOCURABLE COMPOSITIONS FOR ADDITIVE MANUFACTURING AND USE THEREOF | Henkel AG & Co. KGaA (DE) | 2025-08-20 | — | — | EP | claimed |
| US-20250250368-A1 | PHOTOCURABLE COMPOSITIONS FOR THREE-DIMENSIONAL INVESTMENT PATTERN CASTING AND USE THEREOF | HENKEL AG & CO. KGAA (DE) | 2025-08-07 | — | — | US | claimed |
| US-20250223460-A1 | PHOTOCURABLE COMPOSITIONS FOR ADDITIVE MANUFACTURING AND USE THEREOF | HENKEL AG & CO KGAA (DE) | 2025-07-10 | — | — | US | claimed |
| CN-115677890-B | Dendritic fluorescent liquid crystal polymer with aggregation-induced emission characteristic and preparation method thereof | 湖南理工学院 | 2025-06-13 | — | — | CN | claimed |
| CN-118878731-A | Acrylate polymer, acrylate polymer solution, crosslinked resin, preparation method and application | 上海朗亿功能材料有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118812798-A | Acrylic ester copolymer resin and preparation method and application thereof | 昆山石梅新材料科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118475626-A | Photocurable composition for additive manufacturing and use thereof | 汉高股份有限及两合公司 | 2024-08-09 | — | — | CN | claimed |
| WO-2024081115-A1 | PHOTOCURABLE COMPOSITIONS FOR THREE-DIMENSIONAL INVESTMENT PATTERN CASTING AND USE THEREOF | HENKEL AG & CO., KGAA (DE) | 2024-04-18 | — | — | WO | claimed |
| WO-2024081536-A1 | PHOTOCURABLE COMPOSITIONS FOR ADDITIVE MANUFACTURING AND USE THEREOF | HENKEL AG & CO., KGAA (DE) | 2024-04-18 | — | — | WO | claimed |
| EP-0641208-B1 | 4-AZASTEROID 5-ALPHA-REDUCTASE INHIBITORS | MERCK & CO INC (US) | 2000-08-02 | — | — | EP | claimed |
| EP-0888389-A1 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | SurModics, Inc. (US) | 1999-01-07 | — | — | EP | claimed |
| WO-1997034935-A1 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | BSI CORPORATION (US) | 1997-09-25 | — | — | WO | claimed |
| EP-0778284-A2 | New 7-beta-substituted-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors | MERCK & CO. INC. (US) | 1997-06-11 | — | — | EP | claimed |
| US-5620986-A | TREATS BENIGN PROSTATIC HYPERTROPHY, SEBORRHEA, FEMALE HIRSUTISM, AND MALE AND FEMALE PATTEN BALDNESS | MERCK & CO., INC. (US) | 1997-04-15 | — | — | US | claimed |
| EP-0329073-B1 | 2-Substituted carbonylimidazo[4,5-c]quinolines | SHIONOGI & CO (JP) | 1994-12-28 | — | — | EP | claimed |
| US-5324604-A | Multi-active electrophotographic element and imaging process using free radicals as charge transport material | EASTMAN KODAK COMPANY (US) | 1994-06-28 | — | — | US | claimed |
| WO-1993023039-A1 | SUBSTITUTED 4-AZA-5A-ANDROSTAN-ONES AS 5A-REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1993-11-25 | — | — | WO | claimed |
| WO-1993023420-A1 | NEW 7β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1993-11-25 | — | — | WO | claimed |
| US-4140708-A | Asymmetric synthesis of optically active prostaglandins | HOFFMANN-LA ROCHE INC. (US) | 1979-02-20 | — | — | US | claimed |